CORD-19:0376103fd7863b10e41a0f59fe226be9765f34c7 / 21477-22629 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T107","span":{"begin":0,"end":1152},"obj":"Sentence"},{"id":"TextSentencer_T107","span":{"begin":0,"end":1152},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ang-1, angiopoietin-1; APN, adiponectin; AT1, alveolar epithelial type 1; AT2, alveolar epithelial type 2; BMC, bone marrow-derived cells; CdM, conditioned media; EGF, epidermal growth factor; eNOS, endothelial nitric oxide synthase; EPC, endothelial progenitor cell; HGF, hepatocyte growth factor; HSC, hematopoietic stem cell; hAEC, human amnion epithelial cell; hUC, human umbilical cord; hUCB, human umbilical cord blood; IL, interleukin; i.n., intranasal; i.p., intraperitoneal; iPS, induced pluripotent stem; i.t., intratracheal; i.v., intravenous; KGF, keratinocyte growth factor; LPS, lipopolysaccharide; LVRS, lung volume reduction surgery; MMP-2, matrix metalloproteinase 2; MPO, myeloperoxidase; MSC, mesenchymal stem cell; NF-kB, nuclear factor kappa light-chain enhancer of activated B cells; NO, nitric oxide; PaO 2 , partial pressure of oxygen in arterial blood; PGA, polyglycolic acid; RV, right ventricle; SaO 2 , oxygen saturation; TGF-b, transforming growth factor b; Th2, helper T cell type 2; TIMP, tissue inhibitor of metalloproteinase; VEGF, vascular endothelial growth factor. restoration of lung function and exercise capacity."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T107","span":{"begin":0,"end":1152},"obj":"Sentence"}],"text":"Ang-1, angiopoietin-1; APN, adiponectin; AT1, alveolar epithelial type 1; AT2, alveolar epithelial type 2; BMC, bone marrow-derived cells; CdM, conditioned media; EGF, epidermal growth factor; eNOS, endothelial nitric oxide synthase; EPC, endothelial progenitor cell; HGF, hepatocyte growth factor; HSC, hematopoietic stem cell; hAEC, human amnion epithelial cell; hUC, human umbilical cord; hUCB, human umbilical cord blood; IL, interleukin; i.n., intranasal; i.p., intraperitoneal; iPS, induced pluripotent stem; i.t., intratracheal; i.v., intravenous; KGF, keratinocyte growth factor; LPS, lipopolysaccharide; LVRS, lung volume reduction surgery; MMP-2, matrix metalloproteinase 2; MPO, myeloperoxidase; MSC, mesenchymal stem cell; NF-kB, nuclear factor kappa light-chain enhancer of activated B cells; NO, nitric oxide; PaO 2 , partial pressure of oxygen in arterial blood; PGA, polyglycolic acid; RV, right ventricle; SaO 2 , oxygen saturation; TGF-b, transforming growth factor b; Th2, helper T cell type 2; TIMP, tissue inhibitor of metalloproteinase; VEGF, vascular endothelial growth factor. restoration of lung function and exercise capacity."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T97","span":{"begin":41,"end":44},"obj":"Disease"}],"attributes":[{"id":"A97","pred":"mondo_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/MONDO_0008840"}],"text":"Ang-1, angiopoietin-1; APN, adiponectin; AT1, alveolar epithelial type 1; AT2, alveolar epithelial type 2; BMC, bone marrow-derived cells; CdM, conditioned media; EGF, epidermal growth factor; eNOS, endothelial nitric oxide synthase; EPC, endothelial progenitor cell; HGF, hepatocyte growth factor; HSC, hematopoietic stem cell; hAEC, human amnion epithelial cell; hUC, human umbilical cord; hUCB, human umbilical cord blood; IL, interleukin; i.n., intranasal; i.p., intraperitoneal; iPS, induced pluripotent stem; i.t., intratracheal; i.v., intravenous; KGF, keratinocyte growth factor; LPS, lipopolysaccharide; LVRS, lung volume reduction surgery; MMP-2, matrix metalloproteinase 2; MPO, myeloperoxidase; MSC, mesenchymal stem cell; NF-kB, nuclear factor kappa light-chain enhancer of activated B cells; NO, nitric oxide; PaO 2 , partial pressure of oxygen in arterial blood; PGA, polyglycolic acid; RV, right ventricle; SaO 2 , oxygen saturation; TGF-b, transforming growth factor b; Th2, helper T cell type 2; TIMP, tissue inhibitor of metalloproteinase; VEGF, vascular endothelial growth factor. restoration of lung function and exercise capacity."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T134","span":{"begin":112,"end":123},"obj":"Body_part"},{"id":"T135","span":{"begin":341,"end":347},"obj":"Body_part"},{"id":"T136","span":{"begin":376,"end":390},"obj":"Body_part"},{"id":"T137","span":{"begin":404,"end":424},"obj":"Body_part"},{"id":"T138","span":{"begin":404,"end":418},"obj":"Body_part"},{"id":"T139","span":{"begin":419,"end":424},"obj":"Body_part"},{"id":"T140","span":{"begin":619,"end":623},"obj":"Body_part"},{"id":"T141","span":{"begin":862,"end":876},"obj":"Body_part"},{"id":"T142","span":{"begin":871,"end":876},"obj":"Body_part"},{"id":"T143","span":{"begin":1020,"end":1026},"obj":"Body_part"},{"id":"T144","span":{"begin":1116,"end":1120},"obj":"Body_part"}],"attributes":[{"id":"A134","pred":"uberon_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/UBERON_0002371"},{"id":"A135","pred":"uberon_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/UBERON_0000305"},{"id":"A136","pred":"uberon_id","subj":"T136","obj":"http://purl.obolibrary.org/obo/UBERON_0002331"},{"id":"A137","pred":"uberon_id","subj":"T137","obj":"http://purl.obolibrary.org/obo/UBERON_0012168"},{"id":"A138","pred":"uberon_id","subj":"T138","obj":"http://purl.obolibrary.org/obo/UBERON_0002331"},{"id":"A139","pred":"uberon_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A140","pred":"uberon_id","subj":"T140","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"},{"id":"A141","pred":"uberon_id","subj":"T141","obj":"http://purl.obolibrary.org/obo/UBERON_0013755"},{"id":"A142","pred":"uberon_id","subj":"T142","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A143","pred":"uberon_id","subj":"T143","obj":"http://purl.obolibrary.org/obo/UBERON_0000479"},{"id":"A144","pred":"uberon_id","subj":"T144","obj":"http://purl.obolibrary.org/obo/UBERON_0002048"}],"text":"Ang-1, angiopoietin-1; APN, adiponectin; AT1, alveolar epithelial type 1; AT2, alveolar epithelial type 2; BMC, bone marrow-derived cells; CdM, conditioned media; EGF, epidermal growth factor; eNOS, endothelial nitric oxide synthase; EPC, endothelial progenitor cell; HGF, hepatocyte growth factor; HSC, hematopoietic stem cell; hAEC, human amnion epithelial cell; hUC, human umbilical cord; hUCB, human umbilical cord blood; IL, interleukin; i.n., intranasal; i.p., intraperitoneal; iPS, induced pluripotent stem; i.t., intratracheal; i.v., intravenous; KGF, keratinocyte growth factor; LPS, lipopolysaccharide; LVRS, lung volume reduction surgery; MMP-2, matrix metalloproteinase 2; MPO, myeloperoxidase; MSC, mesenchymal stem cell; NF-kB, nuclear factor kappa light-chain enhancer of activated B cells; NO, nitric oxide; PaO 2 , partial pressure of oxygen in arterial blood; PGA, polyglycolic acid; RV, right ventricle; SaO 2 , oxygen saturation; TGF-b, transforming growth factor b; Th2, helper T cell type 2; TIMP, tissue inhibitor of metalloproteinase; VEGF, vascular endothelial growth factor. restoration of lung function and exercise capacity."}